Mon 30 Nov 2009 | 17:43 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Icagen, Inc.

Icagen, Inc. (ICGN.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View ICGN on other exchanges

As of 4:00pm EST

0.46USD

Price Change

-0.02

Percent Change

-4.17%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Hetherington, Seth	56	2006	Senior Vice President - Clinical and Regulatory Affairs
Wagoner, P. Kay	60	1996	President, Chief Executive Officer, Director
Evnin, Anthony	67	1997	Director
Gillings, Dennis	64	1997	Director
Lamotte, Andre	61	1992	Director
Morrison, Richard	72	2004	Director
Simonetti, Martin	51	2005	Director
Olukotun, Adeoye	64	2006	Director
Katz, Richard	45	2008	Chief Financial Officer, Executive Vice President - Finance and Corporate Development, Treasurer
Sanders, Charles	77	2005	Chairman of the Board

Find out more about ICGN.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.